4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC]

686 reported adverse events

Drugs of this class: NITISINONE

These side effects are most commonly reported by patients taking drugs of the 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] class:

# Side effect Count
0 AMINO ACID LEVEL INCREASED 107
1 LIVER TRANSPLANT 98
2 ALPHA 1 FOETOPROTEIN INCREASED 42
3 HEPATOCELLULAR CARCINOMA 41
4 TREATMENT NONCOMPLIANCE 36
5 HEPATIC CIRRHOSIS 34
6 LENTICULAR OPACITIES 34
7 SUCCINYLACETONE INCREASED 31
8 VOMITING 30
9 HEPATIC FAILURE 29
See all common reactions for 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC]

Drugs of the 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SUCCINYLACETONE INCREASED 31 0.9688
1 TYROSINAEMIA 4 0.5714
2 URINE DELTA AMINOLEVULINATE 2 0.2857
3 AMINO ACID LEVEL INCREASED 107 0.2730
4 METASTATIC CHORIOCARCINOMA 1 0.1667
5 AMINO ACID LEVEL DECREASED 17 0.1318
6 LENTICULAR OPACITIES 34 0.1145
7 ACRODERMATITIS ENTEROPATHICA 2 0.1111
8 HEPATIC DYSPLASIA 1 0.0909
9 ALPHA 1 FOETOPROTEIN INCREASED 42 0.0837
See all enriched reactions for 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC]